Sovelbek®

Sovelbek® is indicated for the treatment of chronic hepatitis C virus (HCV) infection in patients 6 years of age and older weighing at least 17 kg.

Additional information

DCI

Sofosbuvir/Velpatasvir

Dosage

400/100 mg

Trade name

Sovelbek®

Name of the originator

Epclusa

Presentation

28 tablets

Specialty

Hépatologie-AAD

See also